Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.